Medically reviewed by Qin Rao, MD Diarrhea and constipation are common causes of fecal incontinence.  Dietary changes and medications can help improve fecal incontinence.Eating smaller meals and going ...

Older women who consumed a proinflammatory diet had a greater risk of fecal incontinence, prospective data from the Nurses' Health Study found. In analyses that adjusted for dietary fiber and other ...

Published in Diseases of the Colon & Rectum, the peer-reviewed study found clinically meaningful symptom reduction, high user engagement, and significant pelvic floor improvements in a real-world ...

A single series of intrarectal botulinum toxin type A injections may provide significant improvement in fecal incontinence symptoms. Submucosal intrarectal injections of botulinum toxin type A (BoNTA) ...

Colorectal Surgeons at Loyola University Health System in Proviso, Ill., say fecal incontinence is a highly underreported and stigmatized condition, according to a news release. The physicians believe ...

The FDA has expanded the use of Renovia’s digital training approach to treating incontinence among women, greenlighting the program as a first-line, home-based option for people with chronic fecal ...

May 5, 2009 (Chicago, Illinois) — Community-dwelling older adults are twice as likely to develop fecal incontinence if they already have urinary incontinence, and depression is associated with the ...

A new, U.S. Food and Drug Administration-approved nonsurgical treatment for fecal incontinence was made available Thursday to select centers of excellence in the United States. The University of ...

Passive incontinence – refers to the involuntary discharge of stool or gas without awareness; Urge incontinence – refers to the discharge of fecal matter in spite of active attempts to retain bowel ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Food insecurity among women was associated with a higher ...

Relationship between ERCC1 C8092A and Mad1 G558A polymorphism with disease progression, and survival in patients with advanced epithelial ovarian cancer treated with induction chemotherapy with ...